These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 2529311)

  • 1. Low molecular weight B cell growth factor-responsive cloned human B cell lines. I. Phenotypic differences and lack of requirement for CD23 (Fc epsilon RII).
    Warrington RJ; Rutherford WJ; Wong SK; Cook JM; Rector ES
    J Immunol; 1989 Oct; 143(8):2546-52. PubMed ID: 2529311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergen-directed expression of Fc receptors for IgE (CD23) on human T lymphocytes is modulated by interleukin 4 and interferon-gamma.
    Prinz JC; Baur X; Mazur G; Rieber EP
    Eur J Immunol; 1990 Jun; 20(6):1259-64. PubMed ID: 2142456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6 augments Fc IgE receptor (Fc epsilon RII/CD23) expression on human monoblastic/monocytic cell lines U937, THP-1, and Mono-Mac-6 but not on blood monocytes. Regulatory effects of IL-4 and IFN-gamma.
    Willheim M; Gessl A; Berger R; Schedle A; Luger T; Föster O; Boltz-Nitulescu G
    J Immunol; 1991 Sep; 147(6):1837-42. PubMed ID: 1832425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD23 antigen is not necessary for human 12-kDa B cell growth factor-mediated B cell proliferation.
    Vazquez A; Mills S; Sharma S; Maizel AL
    Eur J Immunol; 1988 Oct; 18(10):1647-9. PubMed ID: 2973416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation.
    Luo HY; Hofstetter H; Banchereau J; Delespesse G
    J Immunol; 1991 Apr; 146(7):2122-9. PubMed ID: 1826018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional studies examining the subpopulation of human B lymphocytes responding to high molecular weight B cell growth factor.
    Ambrus JL; Chesky L; Stephany D; McFarland P; Mostowski H; Fauci AS
    J Immunol; 1990 Dec; 145(12):3949-55. PubMed ID: 2258603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma.
    Rousset F; Malefijt RW; Slierendregt B; Aubry JP; Bonnefoy JY; Defrance T; Banchereau J; de Vries JE
    J Immunol; 1988 Apr; 140(8):2625-32. PubMed ID: 2965726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-gamma and prostaglandin E2 inhibit IL-4-induced expression of Fc epsilon R2/CD23 on B lymphocytes through different mechanisms without altering binding of IL-4 to its receptor.
    Galizzi JP; Cabrillat H; Rousset F; Ménétrier C; de Vries JE; Banchereau J
    J Immunol; 1988 Sep; 141(6):1982-8. PubMed ID: 2844892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor.
    Kehrl JH; Grove JH; Goldsmith PK; Fauci AS
    Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene B4 potentiates the expression and release of Fc epsilon RII/CD23, and proliferation and differentiation of human B lymphocytes induced by IL-4.
    Dugas B; Paul-Eugene N; Cairns J; Gordon J; Calenda A; Mencia-Huerta JM; Braquet P
    J Immunol; 1990 Nov; 145(10):3406-11. PubMed ID: 2172383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of recombinant IL-4, IFN-alpha, and IFN-gamma on the production of human IgE-binding factor (soluble CD23).
    Delespesse G; Sarfati M; Peleman R
    J Immunol; 1989 Jan; 142(1):134-8. PubMed ID: 2521231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The marmoset B-lymphoblastoid cell line (B95-8) produces and responds to B-cell growth and differentiation factors: role of shed CD23 (sCD23).
    Callard RE; Lau YL; Shields JG; Smith SH; Cairns J; Flores-Romo L; Gordon J
    Immunology; 1988 Nov; 65(3):379-84. PubMed ID: 3145248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
    Tseng CT; Springgate CF; Piela TH; Choi YS
    J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of interleukin 4-promoted CD23 production in human B lymphocytes by transforming growth factor-beta, interferons or anti-CD19 antibody is overriden on engaging CD40.
    Gordon J; Katira A; Strain AJ; Gillis S
    Eur J Immunol; 1991 Aug; 21(8):1917-22. PubMed ID: 1714394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used.
    Callard RE; Rigley KP; Smith SH; Thurstan S; Shields JG
    J Immunol; 1992 May; 148(10):2983-7. PubMed ID: 1374445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of Fc epsilon RII/CD23 on phytohemagglutinin-activated human peripheral blood T lymphocytes. I. Enhancement by IL-2 and IL-4.
    Kawabe T; Maekawa N; Maeda Y; Hosoda M; Yodoi J
    J Immunol; 1991 Jul; 147(2):548-53. PubMed ID: 1830067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of interferon-alpha on the expression and release of the CD23 molecule in hairy cell leukemia.
    Genot E; Sarfati M; Sigaux F; Petit-Koskas E; Billard C; Mathiot C; Falcoff E; Delespesse G; Kolb JP
    Blood; 1989 Nov; 74(7):2455-63. PubMed ID: 2529929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant soluble Fc epsilon receptor II (Fc epsilon RII/CD23) has IgE binding activity but no B cell growth promoting activity.
    Uchibayashi N; Kikutani H; Barsumian EL; Hauptmann R; Schneider FJ; Schwendenwein R; Sommergruber W; Spevak W; Maurer-Fogy I; Suemura M
    J Immunol; 1989 Jun; 142(11):3901-8. PubMed ID: 2523938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for an association between CD23 and the receptor for a low molecular weight B cell growth factor.
    Gordon J; Webb AJ; Walker L; Guy GR; Rowe M
    Eur J Immunol; 1986 Dec; 16(12):1627-30. PubMed ID: 3028819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune dysfunction in mice with plasmacytomas. I. Evidence that transforming growth factor-beta contributes to the altered expression of activation receptors on host B lymphocytes.
    Berg DJ; Lynch RG
    J Immunol; 1991 Apr; 146(8):2865-72. PubMed ID: 1826699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.